Perioperative Management of Direct Oral Anticoagulants
Preoperative Interruption Guidelines
- For adult patients with cardiovascular disease and impaired renal function undergoing surgery, the American College of Chest Physicians recommends holding direct oral anticoagulants (DOACs) for 2-4 days depending on the specific agent, bleeding risk of the procedure, and degree of renal impairment, with dabigatran requiring the longest interruption period in renal dysfunction 1
- The American College of Chest Physicians suggests holding dabigatran for 1 day if creatinine clearance (CrCl) is ≥ 50 mL/min and for 2 days if CrCl < 50 mL/min for low-to-moderate bleeding risk surgery 1
- For high bleeding risk surgery, the American College of Chest Physicians recommends holding dabigatran for 2 days if CrCl ≥ 50 mL/min and for 4 days if CrCl < 50 mL/min 1
- Rivaroxaban, apixaban, and edoxaban can be held for 1 day before low-to-moderate bleeding risk procedures and for 2 days before high bleeding risk procedures, regardless of renal function 1
Bleeding Risk Classification
- The American College of Chest Physicians classifies neuraxial anesthesia, major cancer surgery, joint replacement procedures, abdominal hysterectomy, and laparoscopic cholecystectomy as high bleeding risk procedures requiring 2-4 day interruption of DOACs 1
- The American College of Chest Physicians classifies colonoscopy with biopsy, GI endoscopy with biopsy, abdominal hernia repair, and bronchoscopy with biopsy as low-to-moderate bleeding risk procedures requiring 1-2 day interruption of DOACs 1
- The American College of Chest Physicians considers minor dermatologic procedures, cataract surgery, minor dental procedures, pacemaker/defibrillator implantation, and coronary angiography via radial approach as minimal bleeding risk procedures where anticoagulation can be continued 1
Postoperative Resumption Guidelines
- The American College of Chest Physicians recommends resuming DOACs at least 24 hours after low-to-moderate bleeding risk procedures and 48-72 hours after high bleeding risk procedures 1
- The American Heart Association and the American College of Cardiology suggest that DOACs achieve peak anticoagulant effect within 1-3 hours of intake, requiring cautious postoperative administration 1
Critical Management Principles
- The American College of Chest Physicians states that no heparin bridging is needed for DOACs due to their rapid offset and onset, eliminating the need for bridging with unfractionated heparin or low molecular weight heparin in the perioperative setting 1
- The American College of Cardiology recommends stopping warfarin approximately 5 days before surgery to allow INR normalization and considering bridging with heparin for patients at higher thromboembolism risk 2